The opening of the three-child policy has released the needs of families who are willing to reproduce, the demand for advanced-age pregnancy and childbirth has increased, coupled with people’s eager expectations for prenatal and postnatal care, and the increase in infertility, assisted reproduction has become a health aid. The rigid demand for pregnancy. Paying attention to reproductive health and promoting the application, popularization and technological upgrading of reproductive technology play an important role in promoting the development of assisted reproductive technology.

In order to strengthen the international exchange of reproductive technology and promote mutual learning and technological upgrading in the industry, the 2021 World Reproductive Medicine (Shenzhen) Forum hosted by Guangzhou Zhenghe Exhibition Service Co., Ltd. and China Association of Non-Public Medical Institutions will be held on September 10-12 Held at the Shenzhen Convention and Exhibition Center, the 2021 World Assisted Reproductive Technology Exchange and Development Conference will be held at the Shanghai New International Expo Center from November 16-18. At that time, more than 300 reproductive hospitals and related outpatient clinics at home and abroad will participate in-depth, and nearly 500 reproductive experts will participate in the meeting to jointly create a first-class assisted reproductive academic exchange feast.

The conference will be held around the current hot spots of reproductive medicine, clinical application and discussion of reproductive medicine, male reproductive technology, technical application of assisted reproductive laboratories, fertility and preservation special, reproductive endocrinology and other themes, focusing on the systemic and research of reproductive medicine. Multidisciplinary, strengthen the horizontal connection between reproduction and related specialties, and introduce in-depth new developments in diagnosis and treatment in the field of reproductive medicine from theory to practice, so as to improve participants' awareness of new views and new therapies and the level of diagnosis and treatment of assisted reproductive technology.

It is reported that in recent years, with the postponement of childbearing age, the incidence of infertility has shown a rising trend. The infertility rate in China has risen from 12% in 2007 to about 18% in 2020. 50 million. According to data released by the National Health Commission, as of the end of 2020, there are 536 medical institutions approved to carry out human assisted reproductive technology in China. In the face of a large number of infertile patients, the domestic supply of assisted reproductive technology is already in short supply. Coupled with the stimulation of the “three-child” policy, the demand for assisted reproductive services will continue to rise.

"Assisted reproduction is a technology that benefits mankind. When treating infertility patients, the most important thing is the success rate. The success rate is related to many factors. We hope that through a series of forums, reproduction and related Authoritative experts from the specialties gather to share advanced medical technology and experience information, exchange and learn from each other, and push the development of reproductive technology to a higher level, which will ultimately benefit more infertile families." Zhenghe Exhibition said.

During the conference, the CMTF International Medical Tourism Exhibition with assisted reproduction as the main display section will also be held simultaneously, which will attract hundreds of assisted reproduction centers and service organizations from overseas to attend and participate. Infertile families bring hope for nurturing, and at the same time create new opportunities for promoting exchanges, cooperation and development of the global reproductive health industry.